By Counterforce Health Team in Soliris (eculizumab) —

Work With Your Doctor to Get Soliris (eculizumab) Approved by Aetna (CVS Health) in New Jersey

Quick Answer: Getting Soliris Approved by Aetna (CVS Health) in New Jersey

Eligibility: Soliris (eculizumab) requires prior authorization from Aetna (CVS Health) for FDA-approved conditions including PNH, atypical HUS, generalized myasthenia gravis, and NMOSD. Fastest path: Submit complete prior authorization with diagnostic confirmation, vaccination proof, and detailed medical necessity letter through CVS Specialty Pharmacy. First step today: Call your doctor's office to schedule a visit focused on documenting your diagnosis, treatment failures, and functional impact—this evidence will be crucial for approval. If denied, New Jersey's IHCAP external review through Maximus Federal Services offers a second chance with independent medical experts.

Table of Contents

Set Your Goal: What Approval Requires

Getting Soliris (eculizumab) approved by Aetna (CVS Health) requires meeting specific clinical criteria and providing comprehensive documentation. Your partnership with your healthcare provider is essential—they'll need to demonstrate medical necessity through detailed clinical evidence.

Coverage Requirements at a Glance

Requirement What It Means Where to Find It
Prior Authorization Required for all Soliris prescriptions Aetna 2025 Precertification List
Diagnostic Confirmation Lab evidence of qualifying condition FDA-approved indications in prescribing information
Vaccination Proof Meningococcal vaccines ≥2 weeks before treatment Soliris REMS Program
Site of Care Preference for home/office over hospital outpatient Aetna Infusion Site Policy
Appeals Deadline 180 days for internal, 4 months for external New Jersey IHCAP requirements

Your doctor needs to establish that Soliris is medically necessary for your specific condition and that you meet safety requirements, particularly meningococcal vaccination.

Visit Preparation: Building Your Case

Before your appointment, gather information that will help your doctor build a strong case for Soliris approval. This preparation can significantly improve your chances of getting approved on the first try.

Symptom Timeline Documentation

Create a detailed timeline of your symptoms and how they've impacted your daily life. For each condition, focus on specific evidence:

For PNH (Paroxysmal Nocturnal Hemoglobinuria):

  • Episodes of dark urine, especially in the morning
  • Fatigue levels and how they've worsened
  • Blood transfusion history and dates
  • Thrombotic events or complications

For Atypical HUS:

  • Kidney function changes (creatinine levels if available)
  • Blood pressure readings
  • Signs of hemolysis (fatigue, pale skin)
  • Platelet count trends

For Myasthenia Gravis:

  • Muscle weakness patterns throughout the day
  • Difficulty with daily activities (eating, walking, speaking)
  • Response to current medications
  • Hospitalizations or crisis episodes

Treatment History Summary

Document every therapy you've tried, including:

  • Medication names and doses
  • Duration of each treatment
  • Why each treatment was stopped (lack of efficacy, side effects, contraindications)
  • Specific adverse reactions or intolerances

This history is crucial because Aetna may require evidence of treatment failures before approving Soliris.

Functional Impact Assessment

Prepare specific examples of how your condition affects your ability to work, care for yourself, or participate in activities. Quantify the impact when possible:

  • Days missed from work or school
  • Activities you can no longer perform
  • Need for assistance with daily tasks
  • Quality of life changes

Evidence Kit: Clinical Documentation

Work with your healthcare team to compile the clinical evidence Aetna requires. This documentation forms the foundation of your prior authorization request.

Diagnostic Confirmation Requirements

For PNH:

  • Flow cytometry results showing ≥5% granulocyte or monocyte clone size
  • Elevated lactate dehydrogenase (LDH) levels ≥1.5 times upper normal limit
  • Complete blood count with evidence of hemolysis

For Atypical HUS:

  • Evidence of thrombotic microangiopathy
  • Exclusion of Shiga toxin E. coli HUS (STEC-HUS)
  • Complement studies if available

For Generalized Myasthenia Gravis:

  • Positive acetylcholine receptor (AChR) antibodies
  • Clinical evidence of generalized weakness
  • Electromyography or repetitive nerve stimulation results

Safety Documentation

Meningococcal vaccination is mandatory before starting Soliris. Ensure you have:

  • Documentation of MenACWY and MenB vaccines
  • Vaccination dates (must be ≥2 weeks before first infusion)
  • If urgent treatment is needed, antibiotic prophylaxis plan
Tip: If you need urgent Soliris treatment but haven't been vaccinated, your doctor can start antibiotic prophylaxis while you receive vaccines. Document this clinical decision carefully.

Medical Necessity Letter Structure

Your doctor's medical necessity letter is often the deciding factor in approval. Here's what should be included:

Essential Components

Patient Information and Diagnosis

  • Clear statement of FDA-approved indication
  • ICD-10 codes and diagnostic test results
  • Timeline of symptom onset and progression

Clinical Rationale

  • Why Soliris is the appropriate treatment
  • Evidence supporting medical necessity
  • References to published guidelines or FDA labeling

Treatment History

  • Prior therapies attempted with specific details
  • Reasons for discontinuation or failure
  • Documentation of contraindications to alternatives

Risk-Benefit Analysis

  • Potential consequences of delaying treatment
  • Expected clinical benefits
  • Safety considerations and monitoring plan

Supporting Evidence

Include references to:

  • FDA prescribing information
  • Relevant clinical practice guidelines
  • Peer-reviewed literature supporting use
  • Professional society recommendations

Counterforce Health specializes in helping patients and providers create compelling medical necessity letters that address payer-specific requirements and significantly improve approval rates for complex specialty medications like Soliris.

Peer-to-Peer Support

If your initial prior authorization is denied, your doctor may request a peer-to-peer review with an Aetna medical director. This conversation can often resolve denials when the right clinical information is presented.

Preparing for Peer-to-Peer

Schedule Strategically:

  • Offer multiple availability windows
  • Prepare a concise case summary (2-3 minutes)
  • Have all clinical documentation readily available

Key Discussion Points:

  • Specific diagnostic criteria met
  • Previous treatment failures and reasons
  • Clinical urgency or deterioration
  • Published evidence supporting Soliris use

Documentation:

  • Request written confirmation of the discussion
  • Ask for specific next steps if additional information is needed
  • Follow up within 24-48 hours with any requested documentation

After Your Visit: Next Steps

Once your doctor submits the prior authorization, stay actively involved in the process to ensure timely resolution.

What to Save

  • Copy of the prior authorization submission
  • All supporting clinical documentation
  • Confirmation of submission (reference numbers, dates)
  • Your doctor's contact information for follow-up

Communication Strategy

Use your patient portal to:

  • Message your care team about authorization status
  • Request copies of any additional documentation submitted
  • Alert your doctor to any insurance communications you receive

Timeline Expectations

  • Standard Review: 30-45 days for Aetna decisions
  • Expedited Review: 72 hours for urgent cases
  • Follow-up: Contact your doctor's office if no response within expected timeframe

Respectful Persistence: Follow-Up Strategy

Staying engaged without overwhelming your healthcare team requires a strategic approach to follow-up communications.

Appropriate Cadence

Week 1-2: Allow normal processing time without contact Week 3: Gentle inquiry about status via patient portal Week 4+: More frequent check-ins if approaching clinical urgency

Escalation Path

  1. Patient portal message to care coordinator
  2. Phone call to nurse or medical assistant
  3. Request to speak with prescribing physician
  4. Consider involving patient advocate or case manager

How to Help

  • Provide insurance member services contact information
  • Offer to call Aetna directly for status updates
  • Volunteer to gather additional documentation if needed
  • Research and share relevant clinical literature

Appeals Playbook for New Jersey

If your Soliris prior authorization is denied, New Jersey offers robust appeal rights that can lead to coverage approval.

Internal Appeals with Aetna

Level 1 Internal Appeal:

  • Deadline: 180 days from denial notice
  • How to File: Aetna member portal or written request
  • Timeline: 30 days for standard, 72 hours for expedited
  • Required: Denial letter, additional clinical information, provider letter

Level 2 Internal Appeal (if required):

  • Automatic: Some plans require two levels
  • Timeline: Additional 30 days
  • Focus: Address specific denial reasons with new evidence

New Jersey External Review (IHCAP)

After completing internal appeals, you can request an independent external review through New Jersey's IHCAP program, administered by Maximus Federal Services.

Eligibility:

  • Fully-insured commercial plan issued in New Jersey
  • Completed internal appeal process
  • Denial based on medical necessity

Process:

  • Filing Deadline: 4 months from final internal denial
  • Cost: $25 fee (may be waived for Medicaid)
  • Timeline: 45 days for decision, expedited available
  • Decision: Binding on insurance company

How to File:

  • Online via NJ IHCAP Portal
  • Mail completed forms to Maximus
  • Include all medical records and denial correspondence
From our advocates: We've seen many specialty drug denials overturned through New Jersey's external review process when patients provide comprehensive clinical documentation and clear evidence of medical necessity. The independent physician reviewers often have more specialized knowledge than insurance company medical directors.

For questions about the IHCAP process, contact the dedicated hotline at 1-888-393-1062.

Common Denial Reasons & Solutions

Understanding why Soliris requests are denied helps you address issues proactively.

Denial Reason Solution
Missing vaccination proof Submit documentation of MenACWY and MenB vaccines with dates
Insufficient diagnostic confirmation Provide complete lab results, flow cytometry, or antibody testing
Lack of treatment failure documentation Detail all prior therapies with specific reasons for discontinuation
Site of care restrictions Request home infusion or physician office administration
"Experimental/investigational" Emphasize FDA-approved indication with prescribing information
Step therapy requirements Document contraindications or failures of required first-line treatments

When resubmitting after denial, address each specific reason mentioned in the denial letter with targeted documentation and clinical rationale.

FAQ

How long does Aetna (CVS Health) prior authorization take in New Jersey? Standard reviews typically take 30-45 days, while expedited reviews for urgent cases are completed within 72 hours. You can request expedited review if delaying treatment would cause serious harm.

What if Soliris is non-formulary on my Aetna plan? You can request a formulary exception by demonstrating medical necessity and providing evidence that formulary alternatives are inappropriate, contraindicated, or have failed.

Can I request an expedited appeal in New Jersey? Yes, both Aetna internal appeals and NJ IHCAP external reviews offer expedited processes when delays could cause serious harm to your health.

Does step therapy apply if I failed treatments outside New Jersey? Treatment failures from any location should be documented and considered. Aetna should accept evidence of prior treatment failures regardless of where they occurred.

What happens if I start Soliris before approval? Starting treatment without authorization typically results in claim denials and significant out-of-pocket costs. However, you may be able to appeal for retroactive coverage with strong medical necessity documentation.

How much does Soliris cost without insurance? Soliris is among the most expensive biologics, often exceeding $500,000 annually before manufacturer rebates. Patient assistance programs may be available through Alexion Access Navigator.

Can my doctor file an external appeal on my behalf in New Jersey? Yes, New Jersey allows healthcare providers to file IHCAP external appeals on behalf of patients with written consent.

What if my employer plan is self-funded? Self-funded employer plans follow federal ERISA appeal rules rather than New Jersey state requirements. Contact your plan administrator for specific appeal procedures.

Counterforce Health helps patients, clinicians, and specialty pharmacies turn insurance denials into successful appeals by creating targeted, evidence-backed documentation that addresses payer-specific requirements. Our platform analyzes denial letters and plan policies to draft compelling rebuttals that significantly improve approval rates for complex medications like Soliris.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage decisions depend on individual circumstances and plan terms. Always consult with your healthcare provider and insurance company for guidance specific to your situation. For additional help with insurance appeals in New Jersey, contact the NJ Department of Banking and Insurance Consumer Hotline at 1-800-446-7467.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.